Calithera Biosciences   Report issue

Contributed to NME For profit Phase 1 Phase 2
Founded: San Francisco CA United States (2010)

Organization Overview

First Clinical Trial
2014
NCT02071862
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Calithera Bioscience | Calithera Biosciences, Inc